Warning: The NCBI web site requires JavaScript to function. more...
Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation.
Jochems C, Islander U, Erlandsson M, Verdrengh M, Ohlsson C, Carlsten H.
Arthritis Res Ther. 2005;7(4):R837-43. Epub 2005 Apr 27.
Related citations
Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis.
Jochems C, Islander U, Kallkopf A, Lagerquist M, Ohlsson C, Carlsten H.
Arthritis Rheum. 2007 Oct;56(10):3261-70.
Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30.
Engdahl C, Jochems C, Windahl SH, Börjesson AE, Ohlsson C, Carlsten H, Lagerquist MK.
Arthritis Rheum. 2010 Feb;62(2):524-33.
Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis.
Jochems C, Lagerquist M, Håkansson C, Ohlsson C, Carlsten H.
Clin Exp Immunol. 2008 Jun;152(3):593-7. Epub 2008 Apr 24.
TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
Saidenberg-Kermanac'h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, Cohen-Solal ME.
Bone. 2004 Nov;35(5):1200-7.
Stage-dependent changes in trabecular bone turnover and osteogenic capacity of marrow cells during development of type II collagen-induced arthritis in mice.
Nishida S, Tsurukami H, Sakai A, Sakata T, Ikeda S, Tanaka M, Ito M, Nakamura T.
Bone. 2002 Jun;30(6):872-9.
Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis.
Usui M, Yoshida Y, Tsuji K, Oikawa K, Miyazono K, Ishikawa I, Yamamoto T, Nifuji A, Noda M.
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6653-8. Epub 2004 Apr 20.
The selective cyclooxygenase-2 inhibitor celecoxib reduces bone resorption, but not bone formation, in ovariectomized mice in vivo.
Kasukawa Y, Miyakoshi N, Srivastava AK, Nozaka K, Maekawa S, Baylink DJ, Mohan S, Itoi E.
Tohoku J Exp Med. 2007 Mar;211(3):275-83.
Effects of oestradiol and raloxifene on the induction and effector phases of experimental postmenopausal arthritis and secondary osteoporosis.
Jochems C, Islander U, Erlandsson M, Engdahl C, Lagerquist M, Ohlsson C, Nandakumar KS, Holmdahl R, Carlsten H.
Clin Exp Immunol. 2011 Jul;165(1):121-9. doi: 10.1111/j.1365-2249.2011.04397.x. Epub 2011 Apr 19.
Additional weight bearing during exercise and estrogen in the rat: the effect on bone mass, turnover, and structure.
Tromp AM, Bravenboer N, Tanck E, Oostlander A, Holzmann PJ, Kostense PJ, Roos JC, Burger EH, Huiskes R, Lips P.
Calcif Tissue Int. 2006 Dec;79(6):404-15. Epub 2006 Dec 8.
Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis.
Islander U, Jochems C, Stubelius A, Andersson A, Lagerquist MK, Ohlsson C, Carlsten H.
Arthritis Res Ther. 2011 Jun 20;13(3):R96.
Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice.
Bian L, Josefsson E, Jonsson IM, Verdrengh M, Ohlsson C, Bokarewa M, Tarkowski A, Magnusson M.
Arthritis Res Ther. 2009;11(5):R132. Epub 2009 Sep 1.
Citrus nobiletin suppresses bone loss in ovariectomized ddY mice and collagen-induced arthritis in DBA/1J mice: possible involvement of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis regulation.
Murakami A, Song M, Katsumata S, Uehara M, Suzuki K, Ohigashi H.
Biofactors. 2007;30(3):179-92.
Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis.
Verdrengh M, Carlsten H, Ohlsson C, Tarkowski A.
J Orthop Res. 2007 Mar;25(3):304-10.
Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
Pierroz DD, Bouxsein ML, Rizzoli R, Ferrari SL.
Bone. 2006 Aug;39(2):260-7. Epub 2006 Mar 10.
Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?
Korczowska I, Olewicz-Gawlik A, Trefler J, Hrycaj P, Krzysztof Łacki J.
Clin Rheumatol. 2008 May;27(5):565-72. Epub 2007 Oct 2.
[Effect of kidney deficiency caused by ovariectomy on serum osteocalcin level and tumor necrosis factor in mice with collagen induced arthritis].
Xu S, Lu A, Wang A.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999 Jan;19(1):34-6. Chinese.
A protective effect of Curcuma comosa Roxb. on bone loss in estrogen deficient mice.
Weerachayaphorn J, Chuncharunee A, Mahagita C, Lewchalermwongse B, Suksamrarn A, Piyachaturawat P.
J Ethnopharmacol. 2011 Sep 2;137(2):956-62. Epub 2011 Jul 6.
Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
Christopoulou GE, Stavropoulou A, Anastassopoulos G, Panteliou SD, Papadaki E, Karamanos NK, Panagiotopoulos E.
J Pharm Biomed Anal. 2006 Jun 7;41(3):891-7. Epub 2006 Feb 20.
Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study.
Engvall IL, Svensson B, Tengstrand B, Brismar K, Hafström I; Better Anti-Rheumatic FarmacO Therapy Study Group.
Arthritis Res Ther. 2008;10(6):R128. Epub 2008 Nov 5.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on